Understanding, recognizing, and managing toxicities of targeted anticancer therapies

GK Dy, AA Adjei - CA: a cancer journal for clinicians, 2013 - Wiley Online Library
Answer questions and earn CME/CNE Advances in genomics and molecular biology have
identified aberrant proteins in cancer cells that are attractive targets for cancer therapy …

Bone mineral disease after kidney transplantation

JV Torregrosa, AC Ferreira, D Cucchiari… - Calcified Tissue …, 2021 - Springer
Chronic kidney disease-mineral bone disorder (CKD-MBD) after kidney transplantation is a
mix of pre-existing disorders and new alterations. The final consequences are reflected …

A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism

JM Cruzado, P Moreno, JV Torregrosa… - Journal of the …, 2016 - journals.lww.com
Tertiary hyperparathyroidism is a common cause of hypercalcemia after kidney transplant.
We designed this 12-month, prospective, multicenter, open–label, randomized study to …

[HTML][HTML] Osteoporosis therapy with denosumab in organ transplant recipients

J Brunova, S Kratochvilova… - Frontiers in Endocrinology, 2018 - frontiersin.org
Objective Osteoporosis and fragility fractures represent serious complications for the solid
organ transplant population. The recommended osteoporosis therapy for organ recipients …

[HTML][HTML] Risk factors and management of osteoporosis post-transplant

K Kovvuru, SR Kanduri, P Vaitla, R Marathi, S Gosi… - Medicina, 2020 - mdpi.com
Bone and mineral disorders are common after organ transplantation. Osteoporosis post
transplantation is associated with increased morbidity and mortality. Pathogenesis of bone …

Causes, mechanisms and management of paediatric osteoporosis

O Mäkitie - Nature reviews rheumatology, 2013 - nature.com
Osteoporosis, a skeletal disorder characterized by compromised bone strength and an
increased risk of fractures, is an important paediatric disorder that involves almost all …

Chronic kidney disease progression in kidney transplant recipients: A focus on traditional risk factors

M Carminatti, H Tedesco‐Silva… - …, 2019 - Wiley Online Library
Kidney transplant recipients are a subset of patients with chronic kidney disease (CKD) that
remain at high risk for progression to dialysis and mortality. Recent advances in …

[HTML][HTML] Mineral and bone disorder after kidney transplantation

PT Taweesedt, S Disthabanchong - World journal of transplantation, 2015 - ncbi.nlm.nih.gov
After successful kidney transplantation, accumulated waste products and electrolytes are
excreted and regulatory hormones return to normal levels. Despite the improvement in …

[HTML][HTML] Vitamin D in renal transplantation–from biological mechanisms to clinical benefits

R McGregor, G Li, H Penny, G Lombardi, B Afzali… - American Journal of …, 2014 - Elsevier
Recent developments in our understanding of vitamin D show that it plays a significant role
in immunological health, uniquely occupying both an anti-microbial and immunoregulatory …

Correlates of parathyroid hormone concentration in hemodialysis patients

J Li, MZ Molnar, JJ Zaritsky, JJ Sim… - Nephrology Dialysis …, 2013 - academic.oup.com
Background The implications of chemical hyperparathyroidism on bone and mineral
metabolism measures in maintenance hemodialysis (MHD) are not well known. We …